Research graph
References from Spontaneous binding of potential COVID-19 drugs (Camostat and Nafamostat) to human serine protease TMPRSS2. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1016/j.tim.2016.03.003
10.1016/j.tim.2016.03.003 · External reference
10.1016/s0140-6736(03)14630-2
10.1016/s0140-6736(03)14630-2 · External reference
10.1056/nejmoa1211721
10.1056/nejmoa1211721 · External reference
10.1056/nejmoa2001017
10.1056/nejmoa2001017 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
10.1038/s41586-020-2012-7
10.1038/s41586-020-2012-7 · External reference
Unresolved reference
External reference
Repurposing approved drugs as potential inhibitors of 3CL-protease of SARS-CoV-2: virtual screening and structure based drug design
10.1016/j.compbiolchem.2020.107351 · 2020 · External reference
In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication
10.1038/s41598-020-70143-6 · 2020 · External reference
10.1124/jpet.120.000123
10.1124/jpet.120.000123 · External reference
10.1016/j.cell.2020.02.058
10.1016/j.cell.2020.02.058 · External reference
10.1038/nature02145
10.1038/nature02145 · External reference
10.1016/j.antiviral.2013.09.028
10.1016/j.antiviral.2013.09.028 · External reference
10.1016/j.isci.2020.101212
10.1016/j.isci.2020.101212 · External reference
10.1038/s41423-020-0400-4
10.1038/s41423-020-0400-4 · External reference
Identification of the fusion peptide-containing region in betacoronavirus spike glycoproteins
10.1128/jvi.00015-16 · 2016 · External reference
10.1016/j.cell.2020.02.052
10.1016/j.cell.2020.02.052 · External reference
Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells
10.1073/pnas.2002589117 · 2020 · External reference
Drug resistance in HIV-1
10.1016/j.coviro.2011.10.020 · 2011 · External reference
10.1111/bph.15092
10.1111/bph.15092 · External reference
10.1016/j.biochi.2017.07.016
10.1016/j.biochi.2017.07.016 · External reference
10.1128/jvi.00094-12
10.1128/jvi.00094-12 · External reference
Identification of nafamostat as a potent inhibitor of middle east respiratory syndrome coronavirus S protein-mediated membrane fusion using the split-protein-based cell-cell fusion assay
10.1128/aac.01043-16 · 2016 · External reference
10.3390/v12060629
10.3390/v12060629 · External reference
10.1128/aac.00754-20
10.1128/aac.00754-20 · External reference
10.1016/j.phrs.2020.104859
10.1016/j.phrs.2020.104859 · External reference
10.1126/science.abb9332
10.1126/science.abb9332 · External reference
Protease inhibitors: candidate drugs to inhibit severe acute respiratory syndrome coronavirus 2 replication
10.1620/tjem.251.27 · 2020 · External reference
10.1097/cce.0000000000000284
10.1097/cce.0000000000000284 · External reference
Three cases of treatment with nafamostat in elderly patients with COVID-19 pneumonia who need oxygen therapy
10.1016/j.ijid.2020.05.072 · 2020 · External reference
10.1021/jp973084f
10.1021/jp973084f · External reference
10.1063/1.1808117
10.1063/1.1808117 · External reference
10.1063/1.448118
10.1063/1.448118 · External reference
10.1063/1.328693
10.1063/1.328693 · External reference
10.1002/(sici)1096-987x(199709)18:12<1463::aid-jcc4>3.0.co;2-h
10.1002/(sici)1096-987x(199709)18:12<1463::aid-jcc4>3.0.co;2-h · External reference
10.1063/1.464397
10.1063/1.464397 · External reference
10.1002/jcc.20035
10.1002/jcc.20035 · External reference
10.1186/1756-0500-5-367
10.1186/1756-0500-5-367 · External reference
10.1016/j.csbj.2018.11.009 · Admitted local publication
10.1016/j.csbj.2020.10.041 · Admitted local publication
10.1002/jcc.21256
10.1002/jcc.21256 · External reference
Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2
1999 · External reference
10.3390/molecules25173822
10.3390/molecules25173822 · External reference
10.3934/microbiol.2020021
10.3934/microbiol.2020021 · External reference
Identification of potential anti-TMPRSS2 natural products through homology modelling, virtual screening and molecular dynamics simulation studies
2020 · External reference
The geometry of the reactive site and of the peptide groups in trypsin, trypsinogen and its complexes with inhibitors
10.1107/s010876818300275x · 1983 · External reference
Structural and functional modelling of SARS-CoV-2 entry in animal models
10.1038/s41598-020-72528-z · 2020 · External reference
10.1042/bj20100046
10.1042/bj20100046 · External reference
10.1073/pnas.1104614108
10.1073/pnas.1104614108 · External reference
A semiempirical free energy force field with charge-based desolvation
10.1002/jcc.20634 · 2007 · External reference
Structure-based drug repositioning over the human TMPRSS2 protease domain: search for chemical probes able to repress SARS-CoV-2 Spike protein cleavages
10.1016/j.ejps.2020.105495 · 2020 · External reference
Active site conformational changes of prostasin provide a new mechanism of protease regulation by divalent cations
10.1002/pro.118 · 2009 · External reference
